MoneyWorks4Me

Mercury Laboratories informs about quarterly statement on investor complaints

11 Jul 2016 Evaluate

Mercury Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1841.50
Dr. Reddys Labs. 1243.65
Cipla 1386.75
Lupin 2083.15
Zydus Lifesciences 1213.55
View more..